Thromb Haemost 1988; 60(02): 226-229
DOI: 10.1055/s-0038-1647034
Original Article
Schattauer GmbH Stuttgart

The Endothelial Cell and the Factor VIII Bypassing Activity of Prothrombin Complex Concentrate

Jerome M Teitel
The Division of Hematology, St. Michael's Hospital, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada
,
Hong-Yu Ni
The Division of Hematology, St. Michael's Hospital, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada
,
John J Freedman
The Division of Hematology, St. Michael's Hospital, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada
,
M Bernadette Garvey
The Division of Hematology, St. Michael's Hospital, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Received 11 August 1987

Accepted after revision 02 June 1988

Publication Date:
28 June 2018 (online)

Preview

Summary

Some classical hemophiliacs have a paradoxical hemostatic response to prothrombin complex concentrate (PCC). We hypothesized that vascular endothelial cells (EC) may contribute to this “factor VIII bypassing activity”. When PCC were incubated with suspensions or monolayer cultures of EC, they acquired the ability to partially bypass the defect of factor VIII deficient plasma. This factor VIII bypassing activity distributed with EC and not with the supernatant PCC, and was not a general property of intravascular cells. The effect of PCC was even more dramatic on fixed EC monolayers, which became procoagulant after incubation with PCC. The time courses of association and dissociation of the PCC-derived factor VIII bypassing activity of fixed and viable EC monolayers were both rapid. We conclude that EC may provide a privileged site for sequestration of constituents of PCC which express coagulant activity and which bypass the abnormality of factor VIII deficient plasma.